Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/1/2025

Nitroglycerin Safety in Hypertensive Emergency with CKD Stage 5

Primary Considerations for CKD Stage 5

  • The American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend clevidipine, fenoldopam, or nicardipine as preferred agents over nitroglycerin for acute renal failure, including CKD stage 5, due to their superior safety profile and renal-protective properties 1

Contraindications and Precautions

  • The American College of Cardiology recommends excluding systolic blood pressure <90 mmHg or ≥30 mmHg below baseline as an absolute contraindication to nitroglycerin 4, 1
  • The American Heart Association suggests that extreme bradycardia (<50 bpm) is a contraindication to nitroglycerin, as it can worsen bradycardia and reduce cardiac output 5, 4
  • Right ventricular infarction is a contraindication to nitroglycerin, as these patients are preload-dependent and nitrate-induced venodilation can cause cardiovascular collapse 4, 1
  • Recent phosphodiesterase-5 inhibitor use (within 24 hours for sildenafil/vardenafil, 48 hours for tadalafil) is a contraindication to nitroglycerin 4, 1

Indications for Nitroglycerin in CKD Stage 5

  • The American College of Cardiology recommends nitroglycerin for acute pulmonary edema with hypertension in CKD stage 5 patients 1, 6
  • The American Heart Association suggests that nitroglycerin is indicated for acute coronary syndromes with hypertension in CKD stage 5 patients 1, 6
  • The American College of Cardiology recommends nitroglycerin for hypertensive emergency with active myocardial ischemia 1

Safety Protocols for Nitroglycerin Use

  • The American Heart Association recommends establishing IV access before administering nitroglycerin 5
  • The American College of Cardiology suggests starting with the lowest possible dose (5 mcg/min with non-absorbing tubing) of nitroglycerin 5
  • Continuous intra-arterial blood pressure monitoring is recommended when using nitroglycerin 1
  • Having atropine readily available for worsening bradycardia is recommended when using nitroglycerin 5
  • Being prepared for rapid fluid administration if hypotension occurs is recommended when using nitroglycerin 5
  • Monitoring for excessive blood pressure reduction that could compromise renal perfusion is recommended when using nitroglycerin 6

Preferred Alternative Agents

  • The American College of Cardiology recommends clevidipine as a preferred alternative to nitroglycerin for acute renal failure, including CKD stage 5 1
  • The American Heart Association suggests that fenoldopam has renal-protective dopaminergic effects and is a preferred alternative to nitroglycerin for acute renal failure, including CKD stage 5 1
  • The American College of Cardiology recommends nicardipine as a preferred alternative to nitroglycerin for acute renal failure, including CKD stage 5 1